chr14-70458037-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003813.4(ADAM21):c.538G>T(p.Val180Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,614,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003813.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAM21 | NM_003813.4 | c.538G>T | p.Val180Leu | missense_variant | 2/2 | ENST00000603540.2 | NP_003804.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAM21 | ENST00000603540.2 | c.538G>T | p.Val180Leu | missense_variant | 2/2 | 3 | NM_003813.4 | ENSP00000474385 | P1 | |
ENST00000556646.1 | n.184-4528C>A | intron_variant, non_coding_transcript_variant | 4 | |||||||
ADAM20P1 | ENST00000649019.1 | n.506+2413C>A | intron_variant, non_coding_transcript_variant | |||||||
ADAM21 | ENST00000679631.1 | c.538G>T | p.Val180Leu | missense_variant | 2/2 | ENSP00000506213 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152074Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251342Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135842
GnomAD4 exome AF: 0.0000445 AC: 65AN: 1461880Hom.: 0 Cov.: 70 AF XY: 0.0000495 AC XY: 36AN XY: 727238
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152192Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74418
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 23, 2024 | The c.538G>T (p.V180L) alteration is located in exon 2 (coding exon 1) of the ADAM21 gene. This alteration results from a G to T substitution at nucleotide position 538, causing the valine (V) at amino acid position 180 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at